Returning to ’90s, She Became Famous in Major Surgical Fields

   The two assistants next to me brought a computer and helped to show the ppt content of the lecture.

"Dear colleagues, the special lecture I brought to you today is about the latest research progress in PTCD intrabiliary radiotherapy. This is a technology imported from abroad and has been developed in our country for almost ten years. It is not considered a domestic application. It is a very extensive but relatively mature technology. The technology used in our country is basically iridium 192 wire entering the bile duct as the wire source. As for the placement position and the distance from the tumor, these require more detailed research. Our hospital is This technology has been done for more than eight years, and I have some experience on this to share with my colleagues."

   Don\'t look at other people as professors, he is very humble when discussing academic issues, and he speaks with a certain bookishness.

  The audience was basically silent, and they were all studying quietly.

"The sensitivity of cholangiocarcinoma to chemotherapy is actually not high. The first application of this technology is not cholangiocarcinoma. However, after being used in clinical practice, there are many gratifying findings. For example, if the tumor is smaller than 1.5 cm, only intracavitary cancer can be used. Irradiation can prolong the survival period. For tumors larger than 1.5 cm, it is best to add external irradiation, which is definitely much better than external irradiation alone. The survival period of patients can also be relatively prolonged. "

   It is estimated that he felt a little stuffy in the conference room while talking. Professor Hao adjusted the atmosphere and said to the audience: "If you have any ideas or suggestions from colleagues, you can ask questions and speak at any time. We can see if you raise your hand."

   Hearing him say this, a hand was raised.

The assistant    immediately handed the microphone to this man.

"Excuse me, Dr. Hao, is this technology only used in palliative care? Our hospital once wanted to try to apply it before and after surgery. I don\'t know if your hospital has tried any practice and research in this area. I want to know how to shrink tumors before surgery. And does it make sense to remove residual tumor tissue after surgery? We have read relevant papers, and some colleagues have done similar research but for some reason there are very few cases. Could you please ask Professor Hao to answer related questions?”

   The doctor who asked the question asked a series of questions, all of which were full of practical problems, indicating that he was definitely a front-line doctor.

Professor Hao smiled, asked the other person to sit down, and explained: "About the questions you said, especially the last question, why is this kind of preoperative and postoperative application less common. The main reason is that we shrink tumors before surgery and surgery There is more than one technique for removing residual tumor tissue. Compared with other techniques, as I said at the beginning, the sensitivity of cholangiocarcinoma to radiotherapy is relatively low. With advanced chemotherapy drugs, we can certainly use chemotherapy drugs to shrink tumors. It can only be said that this technology has certain advantages in palliative therapy, in that it can locally destroy the tumor. If there are more advanced drugs in the future, there will be no need for stents to maintain drainage.”

   After the expert finished speaking, the front-line doctors at the grassroots level were inspired and got up to say thank you again.

  The lecture continues. Dose issues, irradiation distance issues, various research tables are listed on the ppt. The audience below the stage took notes while watching some with pens. Although this technique is not considered surgery, adjuvant therapy is just as vital to surgery. When some patients really can\'t have surgery, they really need the doctor to think of a way.

   (end of this chapter)